All filters
Meeting
European Meeting on HIV & Hepatitis 2025
4 Jun 2025 - 6 Jun 2025
Lisbon , Portugal
Hybrid Meeting
Meeting
Conference on Liver Disease in Africa (COLDA) 2024
19 Sep 2024 - 21 Sep 2024
Egypt
Hybrid Meeting
Meeting
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024
18 Sep 2024 - 20 Sep 2024
Liverpool , United Kingdom
Hybrid Meeting
Meeting
APACC 2024
27 Jun 2024 - 29 Jun 2024
Hong Kong
Hybrid Conference
Meeting
International Viral Hepatitis Elimination Meeting (IVHEM) 2023
1 Dec 2023 - 2 Dec 2023
Amsterdam , Netherlands
Hybrid Meeting
Meeting
Conference on Liver Disease in Africa (COLDA) 2023
7 Sep 2023 - 9 Sep 2023
Dar es Salaam , Tanzania
Hybrid Meeting
Meeting
APACC 2023
7 Jun 2023 - 10 Jun 2023
Singapore
Hybrid Meeting
Abstracts
Seroprevalence of SARS-CoV-2 infection and evolution of humoral immune response in PLWHIV in the Ile-de-France area
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Meeting
European Meeting on HIV & Hepatitis 2023
7 Jun 2023 - 9 Jun 2023
Italy
Hybrid Meeting
Abstracts
HIV-1 Integrase Resistance Associated Mutations and the Use of Dolutegravir in Sub- Saharan Africa: A Systematic Review and Meta-Analysis
E. Semengue Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV transmission clusters in Europe: A perspective view of Late presenters and Non-Late presenters
Mafalda N.S. Miranda Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Characterization of SARS-CoV-2 epidemic and transmission dynamics in children over the four COVID-19 waves
R. Scutari  Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing
M. Bellocchi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assays
M. Alkhatib Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies
L. Fiaschi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Levels and durability of humoral and T-specific responses after the booster dose of mRNA BNT162b2 vaccine in residents of a Long Term Care Facility
A. Bergna Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Transmitted drug resistance to integrase based first-line treatment in Europe, 2018-2021
F. Garcia Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV-1 Transmitted drug resistance and transmission clusters in newly diagnosed patients in Portugal between 2014 and 2019
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Reaching the 95-95-95 targets will not eliminate HIV transmission in 2030 among individuals born in sub-Saharan Africa residing in the Netherlands
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV reservoir quantification by combining total HIV-1 DNA assay and intact proviral DNA assay (IPDA) in one triplex digital PCR reaction
M. Delporte Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022